ArticleCancers2011

The role of epidermal growth factor receptor mutations and epidermal growth factor receptor-tyrosine kinase inhibitors in the treatment of lung cancer.

Shih-Chieh Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.